Resources to help
you navigate your specific
type of lung cancer.

When you know more about your disease, you can use what you’ve learned to talk to your doctor to decide the best treatment options for you and make a treatment plan together.

Through the Patient Gateways, you will be able to learn more about your type of lung cancer and get resources that help guide you through your experience with lung cancer. There are also tools that help you find a specialist and clinical trials, and connect you with other people with your type of lung cancer.

Choose your site below. Not sure of your type of lung cancer? Find out more about biomarker testing.


Up to 1 out of 3 patients with NSCLC
(about 25-30%) have a KRAS mutation.

Non-Small Cell Lung Cancer

About 85% of all lung cancers are non-small cell lung cancer.

Coming 2021


EGFR-positive lung cancer represents about 10-15% of lung cancer in the US and generally appears in NSCLC.

Coming 2022


ALK-positive lung cancer represents about 4% of lung cancer in NSCLC.

Coming 2022

Rare Mutations

(ROS1, MET, RET, NTRK, BRAF, Others)

Insights into rare mutations in NSCLC may offer information for understanding and treating these types of biomarkers.

Coming 2022

Small Cell

Small cell lung cancer accounts for 15% of all lung cancers.

Coming 2022

Thank You

to our sponsors who help us provide free resources to the lung cancer community

See our sponsors